Guide
The 503A Pharmacy Survival Guide: How Patient-Specific Compounding Works After the Shortage Ended
Updated June 2026
The shortage is over. The 503B exclusion is moving forward. But 503A compounding pharmacies — state-licensed pharmacies filling individual prescriptions — continue to operate. Here's how, and what you need to verify about your pharmacy.
What Changed and What Didn't
When the FDA removed semaglutide and tirzepatide from the drug shortage list in 2025, it eliminated one specific legal pathway: 503A pharmacies could no longer compound drugs that are "essentially a copy" of the commercially available branded products.
What this did NOT do:
- It did not ban all 503A compounding of semaglutide or tirzepatide. 503A pharmacies can still compound medications that are meaningfully different from commercially available products — different dosing, different formulations, different inactive ingredients, or personalized combinations.
- It did not invalidate existing prescriptions. If you have an active prescription from a licensed provider, your 503A pharmacy can still fill it under applicable state and federal law.
- It did not change state pharmacy board authority. States regulate 503A pharmacies, and regulatory approaches vary by state.
The "Personalization" Framework
503A pharmacies that continue compounding GLP-1 medications typically do so under the personalization framework. This means the compounded product must be meaningfully different from what's commercially available. Examples of legitimate personalization include:
- Dosing variation: Custom doses not available in commercial products (e.g., 0.375mg, 0.75mg titration steps)
- Formulation differences: Sublingual troches, different preservatives, or different concentration per mL
- Combination products: Semaglutide compounded with B12, L-carnitine, or other ingredients
- Patient-specific needs: Allergen-free bases for patients with sensitivities to commercial product excipients
⚠️ Important
Not all claims of "personalization" are legally robust. A pharmacy that simply relabels the same semaglutide formulation as "personalized" without meaningful clinical differentiation is on shaky legal ground. Your provider should be able to explain specifically how your compounded medication differs from the commercial product.
How to Verify Your 503A Pharmacy
| Verification Step | What to Look For | How to Check |
|---|---|---|
| State license | Active pharmacy license in their operating state | State Board of Pharmacy website |
| LegitScript certification | Third-party verification of legitimacy | legitscript.com/verify |
| PCAB accreditation | Compounding-specific quality accreditation (optional but strong signal) | pcab.info |
| Prescription requirement | Must require a valid prescription from a licensed provider | Any pharmacy that ships without one is illegal |
| Certificate of Analysis | Third-party potency and sterility testing | Ask the pharmacy directly — reputable ones provide these on request |
Providers Using Verified 503A Pharmacies
GobyMedsDIRECT AFFILIATE
LegitScript · 503A+503B · Free consult & shipping · Also offers NAD+ & Sermorelin
$99/mo sema bundle
Paid link · Direct affiliate
Compounded medications are not FDA-approved. They are prepared by licensed pharmacies based on a prescription and are not subject to the same regulatory review as commercially manufactured drugs.
Embody
Injectable semaglutide · Free consult · Ships nationwide
$149 first month
Paid link
Compounded medications are not FDA-approved. They are prepared by licensed pharmacies based on a prescription and are not subject to the same regulatory review as commercially manufactured drugs.
Yucca Health
6-month plan pricing · Tirz from $258/mo
Sema from $146/mo
Paid link
Compounded medications are not FDA-approved. They are prepared by licensed pharmacies based on a prescription and are not subject to the same regulatory review as commercially manufactured drugs.
Gala GLP-1
Flat monthly pricing · No dose-dependent increases
$179/mo flat
Paid link
Compounded medications are not FDA-approved. They are prepared by licensed pharmacies based on a prescription and are not subject to the same regulatory review as commercially manufactured drugs.
⚡ Bottom Line
503A compounding of GLP-1s isn't dead — but it's operating in a more constrained environment than during the shortage era. The pharmacies that survive will be the ones with strong compliance, legitimate personalization, and transparent quality testing. Verify your pharmacy. Know what you're getting.
Compare Compounding Pharmacy Providers
See pricing, pharmacy type, and what's included — side by side.
Compare Providers →